401 related articles for article (PubMed ID: 31147626)
1. Adrenocortical carcinoma - towards genomics guided clinical care.
Crona J; Beuschlein F
Nat Rev Endocrinol; 2019 Sep; 15(9):548-560. PubMed ID: 31147626
[TBL] [Abstract][Full Text] [Related]
2. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
Bussey KJ; Demeure MJ
Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
4. 5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications.
Lalli E; Sasano H
Horm Cancer; 2016 Feb; 7(1):44-8. PubMed ID: 26666256
[TBL] [Abstract][Full Text] [Related]
5. Assessment and management of advanced adrenocortical carcinoma using a precision oncology care model.
Elfiky AA; Krishnan Nair HK
Discov Med; 2016 Jan; 21(113):49-56. PubMed ID: 26896602
[TBL] [Abstract][Full Text] [Related]
6. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
7. PERSONALIZED CARE OF PATIENTS WITH ADRENOCORTICAL CARCINOMA: A COMPREHENSIVE APPROACH.
Miller BS; Else T;
Endocr Pract; 2017 Jun; 23(6):705-715. PubMed ID: 28614035
[TBL] [Abstract][Full Text] [Related]
8. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.
Creemers SG; Hofland LJ; Korpershoek E; Franssen GJ; van Kemenade FJ; de Herder WW; Feelders RA
Endocr Relat Cancer; 2016 Jan; 23(1):R43-69. PubMed ID: 26475053
[TBL] [Abstract][Full Text] [Related]
9. Adrenocortical carcinoma.
Soon PS; Sidhu SB
Cancer Treat Res; 2010; 153():187-210. PubMed ID: 19957226
[No Abstract] [Full Text] [Related]
10. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
Shen C; Liu J; Yang X; Jiao W; Wang Y
Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
[TBL] [Abstract][Full Text] [Related]
11. Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis.
Armignacco R; Cantini G; Canu L; Poli G; Ercolino T; Mannelli M; Luconi M
J Endocrinol Invest; 2018 May; 41(5):499-507. PubMed ID: 29080966
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in adrenocortical carcinoma in adults.
Bourdeau I; MacKenzie-Feder J; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):192-7. PubMed ID: 23549307
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of adrenocortical carcinomas is challenging].
Abildgaard J; Pappot H; Petersen PM; Rørth M; Rasmussen ÅK; Toft BG; Sommer P; Daugaard G
Ugeskr Laeger; 2013 Apr; 175(17):1181-5. PubMed ID: 23651782
[TBL] [Abstract][Full Text] [Related]
14. Adrenocortical carcinoma.
Rodgers SE; Evans DB; Lee JE; Perrier ND
Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
[TBL] [Abstract][Full Text] [Related]
15. Advances in translational research of the rare cancer type adrenocortical carcinoma.
Ghosh C; Hu J; Kebebew E
Nat Rev Cancer; 2023 Dec; 23(12):805-824. PubMed ID: 37857840
[TBL] [Abstract][Full Text] [Related]
16. Combined steroidogenic characters of fetal adrenal and Leydig cells in childhood adrenocortical carcinoma.
Fujisawa Y; Sakaguchi K; Ono H; Yamaguchi R; Kato F; Kagami M; Fukami M; Ogata T
J Steroid Biochem Mol Biol; 2016 May; 159():86-93. PubMed ID: 26940356
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice.
Borges KS; Pignatti E; Leng S; Kariyawasam D; Ruiz-Babot G; Ramalho FS; Taketo MM; Carlone DL; Breault DT
Oncogene; 2020 Jul; 39(30):5282-5291. PubMed ID: 32561853
[TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
[TBL] [Abstract][Full Text] [Related]
19. Toward a pathway-centered approach for the treatment of adrenocortical carcinoma.
Bussey KJ; Demeure MJ
Curr Opin Oncol; 2011 Jan; 23(1):34-44. PubMed ID: 21045685
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.
Zheng S; Cherniack AD; Dewal N; Moffitt RA; Danilova L; Murray BA; Lerario AM; Else T; Knijnenburg TA; Ciriello G; Kim S; Assie G; Morozova O; Akbani R; Shih J; Hoadley KA; Choueiri TK; Waldmann J; Mete O; Robertson AG; Wu HT; Raphael BJ; Shao L; Meyerson M; Demeure MJ; Beuschlein F; Gill AJ; Sidhu SB; Almeida MQ; Fragoso MCBV; Cope LM; Kebebew E; Habra MA; Whitsett TG; Bussey KJ; Rainey WE; Asa SL; Bertherat J; Fassnacht M; Wheeler DA; ; Hammer GD; Giordano TJ; Verhaak RGW
Cancer Cell; 2016 May; 29(5):723-736. PubMed ID: 27165744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
